News

Shiv Nadar University develops a molecule with potential to cure COVID-19

The molecule has the potential to be developed into a drug that can cure Acute Respiratory Distress Syndrome (ARDS) in COVID-19 patients

Apr 29, 2020

By : Team ABLE

Radicle Growth-Syngenta launch The Radicle Protein Challenge to invest $1.25m in protein discovery technologies

The application period is open through May 29. Calls on companies of all stages solving protein challenges from plant-based to regenerative Ag can apply for this funding

Apr 29, 2020

By : Team ABLE

DBT announces seed funding grantees under DBT-Cancer Research UK Bilateral Research Initiative for Affordable Approaches to Cancer

The successful applicants have been selected through a rigorous process of screening, filtering, review and evaluation to arrive at seven shortlisted applications.

Apr 29, 2020

By : Team ABLE

The country will be self-reliant by the end of May 2020 in producing indigenous RT-PCR diagnostic kits: Dr. Harsh Vardhan

The sincere efforts of DBT scientists will enable the country to be self-reliant in production of RT-PCR and Antibody test kits by the end of next month, expressed Dr Harsh Vardhan.

Apr 29, 2020

By : Team ABLE

IIT Guwahati collaborates with Hester Biosciences to develop COVID-19 vaccine

IIT Guwahati and Hester Biosciences Limited expect the vaccine to be ready by the end of this year to start animal studies. The work is currently in its early stage of development.

Apr 29, 2020

By : Team ABLE